She will serve as a member of EMD Serono’s leadership team, as well as a member of the Global Compliance Healthcare team led by Betania Glorio, Global Compliance Officer, Healthcare, Merck KGaA, Darmstadt, Germany.
| ROCKLAND, Mass., Feb. 4, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that Elizabeth Varki Jobes, Esq. joined the company as Senior Vice President, Chief Compliance Officer North America. In this role, Ms. Jobes will oversee the strategic direction of EMD Serono’s comprehensive compliance program. She will serve as a member of EMD Serono’s leadership team, as well as a member of the Global Compliance Healthcare team led by Betania Glorio, Global Compliance Officer, Healthcare, Merck KGaA, Darmstadt, Germany.
“It’s an exciting time to be at EMD Serono as we prepare to introduce new therapies into practice and advance existing standards of care,” said Rehan Verjee, President of EMD Serono and Global Head of Innovative Medicine Franchises, Merck KGaA, Darmstadt, Germany. “I am very pleased to welcome Elizabeth at this time given her significant experience in supporting companies like ours achieve on this mission.” Prior to joining EMD Serono, Ms. Jobes served as Global Chief Compliance Officer and Legal Counsel at Spark Therapeutics, Inc., where she was responsible for building a corporate compliance program supporting the launch of the first-approved gene therapy in the United States. Previously, Ms. Jobes held leadership positions across a number of biopharmaceutical companies, including Senior Vice President, Chief Compliance Officer for Auxilium Pharmaceuticals, Inc.; Vice President, Chief Compliance Officer for Adolor (Cubist) Corporation; and Senior Director, Global Compliance for Cephalon, Inc. Ms. Jobes also spent a number of years working in the Philadelphia District Attorney’s Office, first as a trial attorney, then as assistant chief and chief across various units. She earned her J.D. from Rutgers University School of Law and her B.A. from Pennsylvania State University. About EMD Serono, Inc. About Merck KGaA, Darmstadt, Germany The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the company’s business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. Your Contact
SOURCE EMD Serono |
View original content to download multimedia:
